Automated liquid chromatographic analysis of the anti-tumorigenic drugs etoposide (VP 16-213) and teniposide (VM 26)
- 1 January 1983
- journal article
- research article
- Published by Elsevier in Journal of Chromatography B: Biomedical Sciences and Applications
- Vol. 276 (2), 349-357
- https://doi.org/10.1016/s0378-4347(00)85101-4
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- Plasma assay for the antineoplastic agent VP 16-213 (etoposide) using high-performance liquid chromatography with electrochemical detectionJournal of Pharmaceutical and Biomedical Analysis, 1983
- Automated determination of drugs in blood samples after enzymatic hydrolysis using precolumn switching and post-column reaction detectionJournal of Chromatography A, 1983
- Preconcentration and LC analysis of chlorophenols, using a styrene-divinyl-benzene copolymeric sorbent and photochemical reaction detectionChromatographia, 1982
- A sensitive high-performance liquid chromatographic method for determination of the anti-neoplastic agents vp 16-213 and vm 26 in biological fluidsAnalytica Chimica Acta, 1981
- Analysis of the anticancer drugs etoposide (VP 16-213) and teniposide (VM 26) by high-performance liquid chromatography with fluorescence detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- High-performance liquid chromatography determination of 4′-demethyl-epipodophyllotoxin-9-(4,6-O-ethylidene β-d-glucopyranoside) (VP 16-213) in human plasmaJournal of Chromatography B: Biomedical Sciences and Applications, 1981
- Analysis of the anticancer drugs VP 16-213 and VM 26 and their metabolites by high-performance liquid chromatographyJournal of Chromatography B: Biomedical Sciences and Applications, 1980
- Continuous post-column ion-pair extraction detection of some basic organic compounds in normal-phase chromatographyJournal of Chromatography A, 1979